367 related articles for article (PubMed ID: 16352494)
1. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
2. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
4. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
[TBL] [Abstract][Full Text] [Related]
6. NBS1 expression as a prognostic marker in uveal melanoma.
Ehlers JP; Harbour JW
Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009
[TBL] [Abstract][Full Text] [Related]
7. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.
Ehlers JP; Worley L; Onken MD; Harbour JW
Clin Cancer Res; 2005 May; 11(10):3609-13. PubMed ID: 15897555
[TBL] [Abstract][Full Text] [Related]
8. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics of liver metastases from uveal melanoma.
Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
[TBL] [Abstract][Full Text] [Related]
10. Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines.
Landreville S; Vigneault F; Bergeron MA; Leclerc S; Gaudreault M; Morcos M; Mouriaux F; Salesse C; Guérin SL
Pigment Cell Melanoma Res; 2011 Aug; 24(4):643-55. PubMed ID: 21592318
[TBL] [Abstract][Full Text] [Related]
11. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma.
Gordon KB; Thompson CT; Char DH; O'Brien JM; Kroll S; Ghazvini S; Gray JW
Cancer Res; 1994 Sep; 54(17):4764-8. PubMed ID: 8062277
[TBL] [Abstract][Full Text] [Related]
13. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
16. The miRNA expression profile of the uveal melanoma.
Yang C; Wei W
Sci China Life Sci; 2011 Apr; 54(4):351-8. PubMed ID: 21509659
[TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 in uveal malignant melanoma.
Jay V; Yi Q; Hunter WS; Zielenska M
Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
[TBL] [Abstract][Full Text] [Related]
18. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.
Tschentscher F; Hüsing J; Hölter T; Kruse E; Dresen IG; Jöckel KH; Anastassiou G; Schilling H; Bornfeld N; Horsthemke B; Lohmann DR; Zeschnigk M
Cancer Res; 2003 May; 63(10):2578-84. PubMed ID: 12750282
[TBL] [Abstract][Full Text] [Related]
19. Uveal melanoma trapped in the temple of doom.
Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
[No Abstract] [Full Text] [Related]
20. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.
Zuidervaart W; van der Velden PA; Hurks MH; van Nieuwpoort FA; Out-Luiting CJ; Singh AD; Frants RR; Jager MJ; Gruis NA
Br J Cancer; 2003 Nov; 89(10):1914-9. PubMed ID: 14612903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
